Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Serina Therapeutics (SER)
NYSE MKT:SER
RESEARCH TOOLSreports
Serina Therapeutics (SER) Stock Price & Analysis
177 Followers
SER Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.85 - $35.17
Previous Close$10.93
Volume2.67K
Average Volume (3M)5.32K
Market Cap
$27.38M
Enterprise Value$31.25M
Total Cash (Recent Filing)$345.00K
Total Debt (Recent Filing)$4.37M
Price to Earnings (P/E)-0.8
Beta<0.01
Next Earnings
May 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.72
Shares Outstanding2,500,664
10 Day Avg. Volume2,108
30 Day Avg. Volume5,320
Standard Deviation0.25
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)5.71
Price to Sales (P/S)540.32
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue376.51
Enterprise Value/Gross Profit306.38
Enterprise Value/Ebitda-16.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Serina Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SER FAQ
What was Serina Therapeutics’s price range in the past 12 months?
Serina Therapeutics lowest stock price was $9.85 and its highest was $35.17 in the past 12 months.
What is Serina Therapeutics’s market cap?
Currently, no data Available
When is Serina Therapeutics’s upcoming earnings report date?
Serina Therapeutics’s upcoming earnings report date is May 15, 2024 which is in 12 days.
How were Serina Therapeutics’s earnings last quarter?
Serina Therapeutics released its earnings results on Mar 22, 2024. The company reported -$3.203 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.203.
Is Serina Therapeutics overvalued?
According to Wall Street analysts Serina Therapeutics’s price is currently Overvalued.
Does Serina Therapeutics pay dividends?
Serina Therapeutics does not currently pay dividends.
What is Serina Therapeutics’s EPS estimate?
Serina Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Serina Therapeutics have?
Serina Therapeutics has 2,500,747 shares outstanding.
What happened to Serina Therapeutics’s price movement after its last earnings report?
Serina Therapeutics reported an EPS of -$3.203 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.3%.
Which hedge fund is a major shareholder of Serina Therapeutics?
Among the largest hedge funds holding Serina Therapeutics’s share is Defender Capital, LLC.. It holds Serina Therapeutics’s shares valued at N/A.
---
Serina Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 969.0 Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.44%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
269.18%
Trailing 12-Months
Company Description
Serina Therapeutics
AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
---
Technical Analysis
---